Hoth Therapeutics and Silo Pharma Form Joint Venture for Innovative GDNF Therapy Targeting Obesity Hoth Therapeutics and Silo Pharma join forces in a groundbreaking venture to tackle obesity and fatty liver disease with a novel GDNF-based therapy.

Hoth Therapeutics and Silo Pharma Form Joint Venture for Innovative GDNF Therapy Targeting Obesity #United_States #New_York #Hoth_Therapeutics #GDNF #Silo_Pharma